Atara Biotherapeutics (ATRA) EPS (Basic) Growth (5y) (2018 - 2026)
Powered by 
Analysis
Atara Biotherapeutics (ATRA) EPS (Basic) Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.37 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - |
| 3 | Iovance Biotherapeutics | 3.65 Bn | 3.36 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn |
| 5 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.55 Bn | 2.55 Bn | - |
| 7 | Precigen | 2.39 Bn | 2.39 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn |
| 10 | Atara Biotherapeutics | 148.00 Mn | 131.45 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.33% |
| Mar 31, 2026 | 57.57% |
| Dec 31, 2025 | 50.53% |
| Sep 30, 2025 | 57.51% |
| Jun 30, 2025 | 14.95% |
| Mar 31, 2025 | 16.17% |
| Dec 31, 2024 | 46.39% |
| Sep 30, 2024 | 38.27% |
| Jun 30, 2024 | 40.04% |
| Mar 31, 2024 | 31.19% |
| Dec 31, 2023 | 20.69% |
| Sep 30, 2023 | 12.59% |
| Jun 30, 2023 | 10.01% |
| Mar 31, 2023 | 7.23% |
| Dec 31, 2022 | 9.14% |
| Sep 30, 2022 | 4.26% |
| Jun 30, 2022 | 17.01% |
| Mar 31, 2022 | 0.19% |
| Dec 31, 2021 | -9.49% |
| Sep 30, 2021 | -0.53% |